Cargando…

Sexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency

PURPOSE: Although sexuality has been reported to be impaired in females with congenital adrenal hyperplasia (CAH) resulting from 21-hydroxylase deficiency, sexuality in males with CAH so far has remained largely unconsidered. PATIENTS: One of the largest European male cohorts of patients with CAH in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gehrmann, Katharina, Engels, Manon, Bennecke, Elena, Bouvattier, Claire, Falhammar, Henrik, Kreukels, Baudewijntje P C, Nordenstrom, Anna, Reisch, Nicole, Gehrmann, Nicole, Stikkelbroeck, Nike M M L, Quinkler, Marcus, Claahsen-van der Grinten, Hedi L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626486/ https://www.ncbi.nlm.nih.gov/pubmed/31317123 http://dx.doi.org/10.1210/js.2019-00082

Ejemplares similares

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Verhees, Myrthe J. M., et al.
Publicado: (2021)

Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study
por: Falhammar, Henrik, et al.
Publicado: (2018)

Body Image and Quality of Life in Women with Congenital Adrenal Hyperplasia
por: Tschaidse, Lea, et al.
Publicado: (2022)

Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management
por: Sarafoglou, Kyriakie, et al.
Publicado: (2023)

Novel treatments for congenital adrenal hyperplasia
por: Schröder, Mariska A. M., et al.
Publicado: (2022)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020)

Participation of adults with disorders/differences of sex development (DSD) in the clinical study dsd-LIFE: design, methodology, recruitment, data quality and study population
por: Röhle, Robert, et al.
Publicado: (2017)

Long-Term Results of Surgical Treatment and Patient-Reported Outcomes in Congenital Adrenal Hyperplasia—A Multicenter European Registry Study
por: Krege, Susanne, et al.
Publicado: (2022)

Long-Term Outcomes of Congenital Adrenal Hyperplasia
por: Nordenström, Anna, et al.
Publicado: (2022)

Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis
por: Nowotny, Hanna, et al.
Publicado: (2021)

Congenital adrenal hyperplasia in the Nordic countries – a potential base for long-term outcome studies
por: Nordenström, Anna, et al.
Publicado: (2023)

Testicular Adrenal Rest Tumours in Congenital Adrenal Hyperplasia
por: Claahsen-van der Grinten, H. L., et al.
Publicado: (2009)

Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Kocova, Mirjana, et al.
Publicado: (2022)

Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population
por: Sanches, Sarita A, et al.
Publicado: (2012)

PMON191 Current Management of Acute Adrenal Insufficiency Related Adverse Events in Children with Congenital Adrenal Hyperplasia- Results of an International Survey of Specialist Centres
por: Ali, Salma Rashid, et al.
Publicado: (2022)

GATA transcription factors in testicular adrenal rest tumours
por: Engels, Manon, et al.
Publicado: (2017)

The impact of Klinefelter syndrome on socioeconomic status: a multicenter study
por: Franik, Sebastian, et al.
Publicado: (2022)

Quality of life in men with Klinefelter syndrome: a multicentre study
por: Franik, Sebastian, et al.
Publicado: (2023)

Diurnal salivary androstenedione and 17‐hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia
por: Adriaansen, Bas P. H., et al.
Publicado: (2022)

Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
por: Rangaswamaiah, Swetha, et al.
Publicado: (2020)

Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real World Evidence from the I-CAH Registry
por: Farrar, Mallory, et al.
Publicado: (2021)

Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency
por: Al Alawi, Abdullah M., et al.
Publicado: (2019)

Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
por: Adriaansen, Bas P. H., et al.
Publicado: (2022)

Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Kocova, Mirjana, et al.
Publicado: (2020)

Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2020)

The impact of adherence and therapy regimens on quality of life in patients with congenital adrenal hyperplasia
por: Ekbom, Kerstin, et al.
Publicado: (2022)

Assessment of medication adherence in children and adults with congenital adrenal hyperplasia and the impact of knowledge and self‐management
por: Ekbom, Kerstin, et al.
Publicado: (2021)

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021)

SAT303 High Frequency Of Stress Dose Adjustment And Adrenal Crisis In Adult Patients With Congenital Adrenal Hyperplasia
por: Tschaidse, Lea, et al.
Publicado: (2023)

Genotype-Phenotype Correlation in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Cuba
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2021)

Transcriptional comparison of Testicular Adrenal Rest Tumors with fetal and adult tissues
por: Schröder, Mariska A.M., et al.
Publicado: (2022)

Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study
por: Falhammar, Henrik, et al.
Publicado: (2021)

Block and Replace—a New Therapeutic Concept in Congenital Adrenal Hyperplasia?
por: Reisch, Nicole
Publicado: (2021)

Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden
por: Sahlander, Fredrik, et al.
Publicado: (2022)

Multicentre cross-sectional clinical evaluation study about quality of life in adults with disorders/differences of sex development (DSD) compared to country specific reference populations (dsd-LIFE)
por: Rapp, Marion, et al.
Publicado: (2018)

The clinical characteristics and quality of life of 248 pediatric and adult patients with Congenital Adrenal Hyperplasia
por: Shafaay, Edi A., et al.
Publicado: (2023)

Measuring steroids in hair opens up possibilities to identify congenital adrenal hyperplasia in developing countries
por: Waaijers, Selma, et al.
Publicado: (2022)

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019)

Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country
por: Utari, Agustini, et al.
Publicado: (2022)

Corrigendum: Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country
por: Utari, Agustini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mnsihka688l2eihug729vlqir1